Cyclin D1, E-cadherin and beta-catenin expression in FIGO Stage IA cervical squamous carcinoma: Diagnostic value and evidence for epithelial-mesenchymal transition

Histopathology

Volumn 61, Issue 6, 2012, Pages 1125-1133

  Koay, Mei Hui E ^a   Crook, Maxine ^a   Stewart, Colin J R ^b  

^a KING EDWARD MEMORIAL HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Carcinoma; Cervix; Diagnosis; Immunohistochemistry; Invasion; Stage

Indexed keywords

BETA CATENIN; CYCLIN D1; UVOMORULIN;

ARTICLE; CANCER INVASION; CANCER STAGING; DIAGNOSTIC VALUE; EPITHELIAL MESENCHYMAL TRANSITION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERUS BIOPSY;

BETA CATENIN; BIOPSY; CADHERINS; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; CYCLIN D1; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; IMMUNOPHENOTYPING; NEOPLASM STAGING; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 84870391257     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2012.04326.x     Document Type: Article

References (40)

1. Witkiewicz A, Wright T, Ferenczy A, Ronnett B, Kurman R. Carcinoma and other tumours of the cervix. In Kurman RJ, Ellenson H, Ronnett BM eds. Blaustein's pathology of the female genital trac, 6th edn. New York, NY: Springer, 2011; 254-295.
2. Ostor AG, Rome RM. Micro-invasive squamous cell carcinoma of the cervix - a clinicopathologic study of 200 cases with long term follow-up. Int. J. Gynecol. Cancer 1994; 4; 257-264.
3. Burghardt E, Girardi F, Lahousen M, Pickel H, Tamussino K. Microinvasive carcinoma of the uterine cervix (International Federation of Gynecology and Obstetrics Stage IA). Cancer 1991; 67; 1037-1045.
4. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix and endometrium. Int. J. Gynecol. Obstet. 2009; 105; 103-104.
5. Al Nafussi Al, Monaghan H. Squamous carcinoma of the uterine cervix with CIN 3-like pattern: an under-diagnosed lesion. Int. J. Gynecol. Cancer 2002; 12; 185-189.
6. Al Nafussi A. Mini-symposium: early invasion in gynaecological malignancy. Histopathological challenges in assessing invasion in squamous, glandular neoplasia of the cervix. Curr. Diagn. Pathol. 2006; 12; 364-393.
7. Sedlis A, Sall S, Tsukada Y et al. Microinvasive carcinoma of the uterine cervix: a clinical-pathological study. Am. J. Obstet. Gynecol. 1979; 133; 64-74.
8. Lee KB, Lee JM, Park CY, Lee KB, Cho HY, Ha SY. Lymph node metastasis and lymph vascular space invasion in microinvasive squamous cell carcinoma of the uterine cervix. Int. J. Gynecol. Cancer 2006; 16; 1184-1187.
9. Yeasmin S, Nakayama K, Ishikawa M, Nakayama N, Miyazaki K. A case of bilateral pelvic lymph node involvement in stage IA1 squamous cell carcinoma of cervix and a review of the literature. Int. J. Clin. Oncol. 2009; 14; 564-567.
10. Stewart CJR, Crook ML, Little L, Louwen K. Correlation between invasive pattern and immunophenotypic alterations in endocervical adenocarcinoma. Histopathology 2011; 58; 720-728.
11. Little L, Stewart CJR. Cyclin D1 immunoreactivity in normal endocervix and diagnostic value in reactive and neoplastic endocervical lesions. Mod. Pathol. 2010; 23; 611-618.
12. Hirohashi S, Kanai Y. Cell adhesion system and human cancer. Cancer Sci. 2003; 94; 575-581.
13. Klymkowsky MW. Beta-catenin and its regulatory network. Hum. Pathol. 2005; 36; 225-227.
14. Kikuchi A. Tumour formation by genetic mutations in the components of the Wnt signalling pathway. Cancer Sci. 2003; 94; 225-229.
15. Guarino M, Rubino B, Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology 2007; 39; 305-318.
16. Thiery JP. Epithelial-mesenchymal transition in tumour progression. Nat. Rev. Cancer 2002; 2; 442-454.
17. Hugo H, Ackland Ml, Blick T et al. Epithelial-mesenchymal and mesenchymal-epithelial transition in carcinoma progression. J. Cell. Physiol. 2007; 213; 374-383.
18. Donnellan R, Chetty R. Cyclin D1 and human neoplasia. J. Clin. Pathol. Mol. Pathol. 1998; 51; 1-7.
19. Kim JK, Diehl JA. Nuclear cyclin D1: an oncogenic driver in human cancer. J. Cell. Physiol. 2009; 220; 292-296.
20. Li Z, Wang C, Prendergast GC, Pestell RG. Cyclin D1 functions in cell migration. Cell Cycle 2006; 5; 2440-2442.
21. Fu M, Wang C, Li Z, Sakamaki T, Pestell RG. Minireview: cyclin D1: normal and abnormal functions. Endocrinology 2004; 145; 5439-5447.
22. Li W, Thompson CH, Cossart YE et al. The expression of key cell cycle markers and presence of human papillomavirus in squamous cell carcinoma of the tonsil. Head Neck 2004; 26; 1-9.
23. Andl T, Khan T, Pfuhl A et al. Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res. 1998; 58; 5-13.
24. Kim YT, Zhao M. Aberrant cell cycle regulation in cervical carcinoma. Yonsei Med. J. 2005; 46; 597-613.
25. Jung A, Schrauder M, Oswald U et al. The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation. Am. J. Pathol. 2001; 159; 1613-1617.
26. Stewart CJR, Crook MA, Leung YC, Platten M. Expression of cell cycle regulatory proteins in endometrial adenocarcinoma: variations in conventional tumor areas and in microcystic, elongated and fragmented glands. Mod. Pathol. 2009; 22; 725-733.
27. Jung CK, Kang YG, Bae JS, Lim DJ, Choi YJ, Lee KY. Unique patterns of tumor growth related with the risk of lymph node metastasis in papillary thyroid carcinoma. Mod. Pathol. 2010; 23; 1201-1208.
28. Rodriguez-Sastre MA, Gonzalez-Maya L, Delgado R et al. Abnormal distribution of E-cadherin and B-catenin in different histologic types of cancer of the uterine cervix. Gynecol. Oncol. 2005; 97; 330-336.
29. Carico E, Atlante M, Bucci B, Nofroni I, Vecchione A. E-cadherin and alpha-catenin expression during tumor progression of cervical carcinoma. Gynecol. Oncol. 2001; 80; 156-161.
30. Branca M, Giorgi C, Ciotti M et al. Down-regulation of E-cadherin is closely associated with progression of cervical intraepithelial neoplasia but not with high risk HPV or disease outcome in cervical cancer. Eur. J. Gynaecol. Oncol. 2006; 27; 215-223.
31. Hagemann T, Bozanovic T, Hooper S et al. Molecular profiling of cervical cancer progression. Br. J. Cancer 2007; 96; 321-328.
32. Yi JY, Hur KC, Lee E, Jin YJ, Arteaga CL, Sonerin YS. TGFB-1 mediated epithelial to mesenchymal transition is accompanied by invasion in the Si Ha cell line. Eur. J. Cell Biol. 2002; 81; 457-468.
33. Hsu YM, Chen YF, Chou CY et al. KCl cotransporter-3 downregulates E-cadherin/beta-catenin complex to promote epithelial-mesenchymal transition. Cancer Res. 2007; 67; 11064-11072.
34. Lee MY, Chou CY, Tang MJ, Shen MR. Epithelial-mesenchymal transition in cervical cancer: correlation with tumour progression, epidermal growth factor receptor overexpression, and snail up-regulation. Clin. Cancer Res. 2008; 14; 4743-4750.
35. Srivastava S, Ramdass B, Nagarajan S, Rehman M, Mukherjee G, Krishna S. Notch1 regulates the functional contribution of Rhoc to cervical carcinoma progression. Br. J. Cancer 2010; 102; 196-205.
36. Lee MY, Shen MR. Epithelial-mesenchymal transition in cervical carcinoma. Am. J. Transl. Res. 2012; 4; 1-13.
37. Tomlinson JS, Alpaugh ML, Barsky SH. An intact overexpressed E-cadherin/alpha, beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma. Cancer Res. 2001; 61; 5231-5241.
38. Sakuma Y, Takeuchi T, Nakamura Y et al. Lung adenocarcinoma cells floating in lymphatic vessels resist anoikis by expressing phosphorylated Src. J. Pathol. 2010; 220; 574-585.
39. Cowley GP, Smith ME. Modulation of E-cadherin expression and morphological phenotype in the intravascular component of adenocarcinomas. Int. J. Cancer 1995; 60; 325-329.
40. Gupta A, Deshhpande CG, Badve S. Role of E-cadherins in development of lymphatic tumor emboli. Cancer 2003; 97; 2341-2347.